Gene expression in atherogenesis
It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. Differential gene expression in vascular cells and in blood cells, due to ge...
Saved in:
| Published in: | Thrombosis and haemostasis Vol. 86; no. 1; p. 404 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Germany
01.07.2001
|
| Subjects: | |
| ISSN: | 0340-6245 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. Differential gene expression in vascular cells and in blood cells, due to gene-gene and gene-environment interactions can be considered the molecular basis for this disease. To comprehend the coherence of the complex genetic response to systemic and local atherosclerotic challenges, one needs accessible high through-put technologies to analyze a panel of differentially expressed genes and to describe the interactions between and among their gene products. Fortunately, new technologies have been developed which allow a complete inventory of differential gene expression, i.e. DD/RT-PCR, SAGE and DNA micro-array. The initial data on the application of these technologies in cardiovascular research are now being reported. This review summarizes a number of key observations. Special attention is paid to a few central transcription factors which are differentially expressed in endothelial cells, smooth muscle cells or monocytes/ macrophages. Recent data on the role of nuclear factor-kappaB (NF-kappaB) and peroxisome proliferation-activating receptors (PPARs) are discussed. Like the PPARs, the NGFI-B subfamily of orphan receptors (TR3, MINOR and NOT) also belongs to the steroid/thryroid hormone receptor superfamily of transcription factors. We report that this subfamily is specifically induced in a sub-population of neointimal smooth muscle cells. Furthermore, intriguing new data implicating the Sp/XKLF family of transcription factors in cell-cell communication and maintenance of the atherogenic phenotype are mentioned. A member of the Sp/XKLF family, the shear stress-regulated lung Krüppel-like factor (LKLF) is speculated to be instrumental for the communication between endothelial cells and smooth muscle cells. Taken together, the expectation is that the fundamental knowledge obtained on atherogenesis and the data that will be acquired during the coming decade with the new, powerful high through-put methodologies will lead to novel modalities to treat patients suffering from cardiovascular disease. In view of the phenotypic changes of vascular and blood-borne cells during atherogenesis, therapeutic interventions likely will focus on reversal of an acquired phenotype by gene therapy approach or by using specific drugs which interfere with aberrant gene expression. |
|---|---|
| AbstractList | It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. Differential gene expression in vascular cells and in blood cells, due to gene-gene and gene-environment interactions can be considered the molecular basis for this disease. To comprehend the coherence of the complex genetic response to systemic and local atherosclerotic challenges, one needs accessible high through-put technologies to analyze a panel of differentially expressed genes and to describe the interactions between and among their gene products. Fortunately, new technologies have been developed which allow a complete inventory of differential gene expression, i.e. DD/RT-PCR, SAGE and DNA micro-array. The initial data on the application of these technologies in cardiovascular research are now being reported. This review summarizes a number of key observations. Special attention is paid to a few central transcription factors which are differentially expressed in endothelial cells, smooth muscle cells or monocytes/ macrophages. Recent data on the role of nuclear factor-kappaB (NF-kappaB) and peroxisome proliferation-activating receptors (PPARs) are discussed. Like the PPARs, the NGFI-B subfamily of orphan receptors (TR3, MINOR and NOT) also belongs to the steroid/thryroid hormone receptor superfamily of transcription factors. We report that this subfamily is specifically induced in a sub-population of neointimal smooth muscle cells. Furthermore, intriguing new data implicating the Sp/XKLF family of transcription factors in cell-cell communication and maintenance of the atherogenic phenotype are mentioned. A member of the Sp/XKLF family, the shear stress-regulated lung Krüppel-like factor (LKLF) is speculated to be instrumental for the communication between endothelial cells and smooth muscle cells. Taken together, the expectation is that the fundamental knowledge obtained on atherogenesis and the data that will be acquired during the coming decade with the new, powerful high through-put methodologies will lead to novel modalities to treat patients suffering from cardiovascular disease. In view of the phenotypic changes of vascular and blood-borne cells during atherogenesis, therapeutic interventions likely will focus on reversal of an acquired phenotype by gene therapy approach or by using specific drugs which interfere with aberrant gene expression.It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. Differential gene expression in vascular cells and in blood cells, due to gene-gene and gene-environment interactions can be considered the molecular basis for this disease. To comprehend the coherence of the complex genetic response to systemic and local atherosclerotic challenges, one needs accessible high through-put technologies to analyze a panel of differentially expressed genes and to describe the interactions between and among their gene products. Fortunately, new technologies have been developed which allow a complete inventory of differential gene expression, i.e. DD/RT-PCR, SAGE and DNA micro-array. The initial data on the application of these technologies in cardiovascular research are now being reported. This review summarizes a number of key observations. Special attention is paid to a few central transcription factors which are differentially expressed in endothelial cells, smooth muscle cells or monocytes/ macrophages. Recent data on the role of nuclear factor-kappaB (NF-kappaB) and peroxisome proliferation-activating receptors (PPARs) are discussed. Like the PPARs, the NGFI-B subfamily of orphan receptors (TR3, MINOR and NOT) also belongs to the steroid/thryroid hormone receptor superfamily of transcription factors. We report that this subfamily is specifically induced in a sub-population of neointimal smooth muscle cells. Furthermore, intriguing new data implicating the Sp/XKLF family of transcription factors in cell-cell communication and maintenance of the atherogenic phenotype are mentioned. A member of the Sp/XKLF family, the shear stress-regulated lung Krüppel-like factor (LKLF) is speculated to be instrumental for the communication between endothelial cells and smooth muscle cells. Taken together, the expectation is that the fundamental knowledge obtained on atherogenesis and the data that will be acquired during the coming decade with the new, powerful high through-put methodologies will lead to novel modalities to treat patients suffering from cardiovascular disease. In view of the phenotypic changes of vascular and blood-borne cells during atherogenesis, therapeutic interventions likely will focus on reversal of an acquired phenotype by gene therapy approach or by using specific drugs which interfere with aberrant gene expression. It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and progression of atherosclerosis as compared to normal circumstances. Differential gene expression in vascular cells and in blood cells, due to gene-gene and gene-environment interactions can be considered the molecular basis for this disease. To comprehend the coherence of the complex genetic response to systemic and local atherosclerotic challenges, one needs accessible high through-put technologies to analyze a panel of differentially expressed genes and to describe the interactions between and among their gene products. Fortunately, new technologies have been developed which allow a complete inventory of differential gene expression, i.e. DD/RT-PCR, SAGE and DNA micro-array. The initial data on the application of these technologies in cardiovascular research are now being reported. This review summarizes a number of key observations. Special attention is paid to a few central transcription factors which are differentially expressed in endothelial cells, smooth muscle cells or monocytes/ macrophages. Recent data on the role of nuclear factor-kappaB (NF-kappaB) and peroxisome proliferation-activating receptors (PPARs) are discussed. Like the PPARs, the NGFI-B subfamily of orphan receptors (TR3, MINOR and NOT) also belongs to the steroid/thryroid hormone receptor superfamily of transcription factors. We report that this subfamily is specifically induced in a sub-population of neointimal smooth muscle cells. Furthermore, intriguing new data implicating the Sp/XKLF family of transcription factors in cell-cell communication and maintenance of the atherogenic phenotype are mentioned. A member of the Sp/XKLF family, the shear stress-regulated lung Krüppel-like factor (LKLF) is speculated to be instrumental for the communication between endothelial cells and smooth muscle cells. Taken together, the expectation is that the fundamental knowledge obtained on atherogenesis and the data that will be acquired during the coming decade with the new, powerful high through-put methodologies will lead to novel modalities to treat patients suffering from cardiovascular disease. In view of the phenotypic changes of vascular and blood-borne cells during atherogenesis, therapeutic interventions likely will focus on reversal of an acquired phenotype by gene therapy approach or by using specific drugs which interfere with aberrant gene expression. |
| Author | Monajemi, H Arkenbout, E K Pannekoek, H |
| Author_xml | – sequence: 1 givenname: H surname: Monajemi fullname: Monajemi, H organization: Department of Biochemistry, Academic Medical Center, University of Amsterdam, The Netherlands – sequence: 2 givenname: E K surname: Arkenbout fullname: Arkenbout, E K – sequence: 3 givenname: H surname: Pannekoek fullname: Pannekoek, H |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11487030$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1jz1PwzAURT0U0Q9YGVEmNsN79rNjj6iCglSJpXvkJC8QlDghbiT491SiTGe4R1c6a7GIQ2QhbhDuEYx5SBJA5xItWqXdQqxAE0iryCzFOqVPALTkzaVYIpLLQcNKZDuOnPH3OHFK7RCzNmbh-MHT8H4aUpuuxEUTusTXZ27E4fnpsH2R-7fd6_ZxLytD7ihtTdRoqhuvq9AQmrz2rJyufR4sByjRe3DIAT1oG6hSFJy3jOjLnJXaiLu_23EavmZOx6JvU8VdFyIPcypyBAtE-iTensW57Lkuxqntw_RT_CepX4EwS4A |
| CitedBy_id | crossref_primary_10_1016_j_pep_2004_06_024 crossref_primary_10_1089_153968503321642624 crossref_primary_10_1097_00041433_200204000_00014 crossref_primary_10_1074_jbc_M300088200 crossref_primary_10_1111_j_1368_5031_2005_00439_x crossref_primary_10_1124_pr_55_1_5 crossref_primary_10_1016_S0006_2952_03_00546_X crossref_primary_10_1038_sj_jid_5700943 crossref_primary_10_1161_01_RES_0000082978_92494_B1 crossref_primary_10_1080_07853890310019961 crossref_primary_10_1161_CIRCRESAHA_106_145235 crossref_primary_10_1016_S1885_5857_06_60174_6 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1055/s-0037-1616238 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 11487030 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- .55 .GJ 0R~ 0VX 123 1KJ 4.4 53G 5RE AAQQT ABJNI ABOCM ACGFO ACGFS AENEX AFFNX AHRSK ALMA_UNASSIGNED_HOLDINGS BR6 C45 CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P H13 J5H NPM OVD P2P RTC RTE SJN TEORI X7M ZGI ZXP 7X8 ACNUY AGCGI |
| ID | FETCH-LOGICAL-c548t-6d44f34df93caf4157d9e283d97a6ea0b199081ea19036a4c24a896e119b7e22 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 21 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000169965600046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0340-6245 |
| IngestDate | Fri Jul 11 12:03:01 EDT 2025 Thu Jan 02 21:53:30 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c548t-6d44f34df93caf4157d9e283d97a6ea0b199081ea19036a4c24a896e119b7e22 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 11487030 |
| PQID | 71060443 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_71060443 pubmed_primary_11487030 |
| PublicationCentury | 2000 |
| PublicationDate | 2001-07-01 |
| PublicationDateYYYYMMDD | 2001-07-01 |
| PublicationDate_xml | – month: 07 year: 2001 text: 2001-07-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany |
| PublicationTitle | Thrombosis and haemostasis |
| PublicationTitleAlternate | Thromb Haemost |
| PublicationYear | 2001 |
| SSID | ssj0016495 |
| Score | 1.7550762 |
| SecondaryResourceType | review_article |
| Snippet | It is conceivable that the extent and spatio-temperal expression of dozens or even a few hundred genes are significantly altered during the development and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 404 |
| SubjectTerms | Animals Arteriosclerosis - etiology Arteriosclerosis - genetics Arteriosclerosis - pathology Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Gene Expression Gene Expression Profiling Humans Muscle, Smooth, Vascular - metabolism Muscle, Smooth, Vascular - pathology Transcription Factors - physiology |
| Title | Gene expression in atherogenesis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/11487030 https://www.proquest.com/docview/71060443 |
| Volume | 86 |
| WOSCitedRecordID | wos000169965600046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV05T8MwFH4qFCEW7qOcGVitJrbj2BISQoiKgVYdOnSrHB-oS1JIQfx8nnOICTGwZLMUX-_77Pf5ewC3yIkTw0UamBsl3MWO5JYbIhUVyrPYMF27679kk4mcz9W0B3fdW5ggq-xiYh2obWnCHfkQkVDEnLP71RsJNaNCbrUtoLEBfYZEJmzLbP6TQxC8rrkSsyBwpzztLBvTdFiR4LtCkO0g-svfyWUNMqO9__3ePuy25DJ6aFbDAfRccQjb4zZ9fgRRMJmO3Fcrfi2iZRHVDLB8DSFvWR3DbPQ0e3wmbYkEYvCosSbCcu4Zt14xoz2CcWaVQ8ZgVaaF03GeINrIxGnEfSY0N5RrqYRLEpVnjtIT2CzKwp1BJGhuHcfThpc4Vy6RFgcwTQ2Lc-XjTA_gpuv4AldgSCvowpUf1aLr-gBOm7FbrBqjjPDiWYaIcv5n2wvYacRdQQd7CX2Pe89dwZb5XC-r9-t6YvE7mY6_AXmSqo0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+expression+in+atherogenesis&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Monajemi%2C+H&rft.au=Arkenbout%2C+E+K&rft.au=Pannekoek%2C+H&rft.date=2001-07-01&rft.issn=0340-6245&rft.volume=86&rft.issue=1&rft.spage=404&rft_id=info:doi/10.1055%2Fs-0037-1616238&rft_id=info%3Apmid%2F11487030&rft_id=info%3Apmid%2F11487030&rft.externalDocID=11487030 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-6245&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-6245&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-6245&client=summon |